your market intelligence analyst
Search Results
Edit Save
12,321 results
Healio News 10/20/2019 20:04
ATLANTA — Although progress has been made in diagnosing and treating patients with familial hypercholesterolemia, more work is needed in these areas, according to a presentation at the FH Foundation’s FH Global Summit. Substantial progress has been made with regards to familial hypercholesterolemia (FH) since 2012, Joshua W. Knowles, MD, PhD, assistant professor of medicine (cardiovascular medicine) at the Stanford University Medical Center, volunteer chief medical advisor for the FH Foundation and Cardiology Today Next Gen Innovator, said during the presentation. At that time,
Healio News 10/20/2019 11:24
NEW ORLEANS — Use of spirometry with bronchodilator testing can help reduce overdiagnosis of COPD as well as help differentiate COPD from asthma and asthma-COPD overlap syndrome, researchers reported at the CHEST Annual Meeting. “Despite the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendation to use the post-bronchodilator FEV1/FVC ratio for diagnosis, spirometry with bronchodilator testing is not routinely used in clinical practice to diagnose COPD,” Srinadh Annangi, MD, from the University of Kentucky School of Medicine, told Healio Pulmonology. “In.
Healio News 10/20/2019 10:18
NEW ORLEANS — Switching inhaler types due to insurance formulary changes may lead to reduced lung function in children with asthma, according to data presented at the CHEST Annual Meeting. “Insurance formulary changes have been a major reason why many of our children with asthma who were otherwise stable have been switched from one long-term controller to another. Anecdotally, these changes cause considerable confusion for both families and health care professionals,” Scott G. Bickel, MD, from the University of Louisville School of Medicine, wrote in an email to Healio.
Healio News 10/19/2019 14:35
CHICAGO — Two endoscopic scoring indices originally designed for use in adults are reliable for endoscopic assessment in children with ulcerative colitis, according to research presented at NASPGHAN 2019. Amanda Ricciuto, MD , PhD, of the Hospital for Sick Children in Toronto, said that in the shift to endoscopic remission as a treatment target in UC, the UC Endoscopic Index of Severity (UCEIS) and the Mayo Endoscopic Sub-score (MES) have become valuable tools in assessing adult patients. “Neither has been formally validated or assessed in pediatrics,” she said during her.
Healio News 10/19/2019 13:14
CHICAGO — Researchers determined clinical scores that assessed short-term risks for liver disease associated with isolated heart transplantation with the Fontan procedure in pediatric patients, according to a study presented at NASPGHAN 2019. “Long term survivors of the Fontan operation universally develop hepatic congestion, hepatic fibrosis and portal hypertension of varying degrees,” Dellys Soler-Rodriguez, MD, from the Emory University School of Medicine, said during his presentation, “Assessment of the severity of this Fontan associated liver disease (FALD) is.
Healio News 10/19/2019 11:00
Researchers were “encouraged” by the interim results from a phase 1 study of a novel influenza vaccine approach they hope will one day protect patients from both seasonal and pandemic influenza. They tested the ability of chimeric hemagglutinin (cHA)-based universal influenza vaccine candidates to target the conserved stalk of hemagglutinin surface proteins, rather than the globular head. “We are very encouraged that the preliminary data are compelling in terms of inducing a protective and long-lasting immune response in humans,” Peter Palese, PhD, professor and chair of.
Healio News 10/19/2019 09:04
CHICAGO — Despite some advantages, using carbon dioxide for endoscopic insufflation comes with a few safety concerns, according to research presented at the NASPGHAN Annual Meeting. Chinenye R. Dike, MD, of the University of Nebraska Medical Center, said that while CO2 has been used for many years in adult GI, air has been the standard in pediatrics. “We do know that there is compelling adult data on CO2 use for a variety of procedures, for colonoscopy, upper endoscopy and even advanced procedures,” she said in her presentation. “But what about using it in children?”
Healio News 10/19/2019 08:00
As drug-eluting stent technology has evolved, stent thrombosis has become less of a risk and the standard recommendation of 1 year of dual antiplatelet therapy after PCI is being challenged, especially for patients at high bleeding risk. Healio was on-site at TCT 2019, which offered a number of late-breaking presentations on optimizing pharmacotherapy after PCI. Below are some of the highlights. TWILIGHT: Switching to ticagrelor monotherapy 3 months post-PCI lowers bleeding vs. DAPT SAN FRANCISCO — Among patients who underwent PCI with a DES and were prescribed DAPT for 3 months,
Healio News 10/19/2019 08:00
Breast Cancer Awareness Month is observed every October. The international health campaign is designed to increase awareness of the disease and raise money to fund research for prevention, earlier detection and more effective treatment. In conjunction with this observance, HemOnc Today and Healio highlight 10 research updates in breast cancer treatment, diagnosis, prevention and survivorship.
Healio News 10/19/2019 07:00
Endocrine Today has compiled a list of the top five news reports posted from the Cardiometabolic Health Congress, held from Oct. 10 to 13 in Chicago. readers were interested in the potential of simultaneous combination therapy in treating type 2 diabetes, how to address high insulin prices, how technology is transforming diabetes management and more. All content from the meeting is available under the Meeting News tab. Simultaneous combination therapy shows major potential in type 2 diabetes When treating patients with type 2 diabetes, physicians may have more success if.
Healio News 10/18/2019 17:52
Johnson & Johnson is voluntarily recalling one lot of its Johnson’s Baby Powder product due to the presence of asbestos, according to a press release from the FDA. The FDA found chrysotile fibers during testing of this lot (#22318RB) and noted that it found no asbestos when testing another lot of the product. According to the release, the FDA “is not aware of any adverse events relating to exposure to the lot of affected products” but advised against the use of this lot of the product and recommended seeking a refund from the company. “I understand today’s.
Healio News 10/18/2019 17:00
SAN FRANCISCO — While small iris defects can be treated with sutures, patients with large iris defects who have poor cosmetics and light sensitivity can be successfully treated with artificial irises, according to a speaker here. “Not only do these devices reduce light and glare sensitivity, but what they do for a person’s psychology, their emotional state, their ability to interact with people is beyond study,” Kevin M. Miller, MD, said as he delivered the Charles D. Kelman Lecture at the American Academy of Ophthalmology annual meeting. Four companies currently produce.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios